[Federal Register Volume 68, Number 231 (Tuesday, December 2, 2003)]
[Notices]
[Pages 67474-67475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29977]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 19, 2003, and published in the Federal 
Register on September 2, 2003, (68 FR 52224), Cambridge Isotope 
Laboratories, Inc., 50 Frontage Road, Andover, Massachusetts 01810, 
made application by renewal to the Drug Enforcement Administration for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methaqualone (2565)........................  I
Dimethyltryptamine (7435...................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Secobartbital (2315).......................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to produce isotope labeled standards for drug 
analysis.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Cambridge Isotope Laboratories, 
Inc. to manufacture the listed controlled substances is consistent with 
the public interest at this time. DEA has investigated Cambridge 
Isotope Laboratories, Inc. to ensure that the company's registration is 
consistent with the public interest. this investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.

[[Page 67475]]

Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed is granted.

    Dated: November 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-29977 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M